Agenus | AGEN - Market Capitalization


Agenus reported $2.57B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Celldex Therapeutics USD 2.11B 307M Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Glaxosmithkline GBP 108.55B 736M Jul/2026
Incyte USD 18.73B 660M Mar/2026
J&J USD 602.98B 8.38B Jul/2026
Jiangsu Hengrui CNY 366.9B 29.67B Mar/2026
Karyopharm Therapeutics USD 1.12B 989M Jul/2026
MacroGenics USD 287M 103M Jul/2026
Merck EUR 46.78B 6.52B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Northwest Biotherapeutics USD 270M 86M Jun/2026
Novartis USD 257.14B 50.62B Jul/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 153.81B 12.24B Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Veracyte USD 2.57B 758M Mar/2026